Abstract
BackgroundThe clinical response of rituximab (RTX) is related to the degree of B cell depletion, although flow cytometry analysis of peripheral blood leukocytes after RTX therapy has shown some effects...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have